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Abstract
Background: Previous work showed that the functional cardiac effect of dietary alpha-linolenic
acid (ALA) in rats requires a long feeding period (6 months), although a docosahexaenoic (DHA)
acid-supply affects cardiac adrenergic response after 2 months. However, the total cardiac
membrane n-3 polyunsaturated fatty acid (PUFA) composition remained unchanged after 2 months.
This delay could be due to a specific reorganization of the different subcellular membrane PUFA
profiles. This study was designed to investigate the evolution between 2 and 6 months of diet
duration of the fatty acid profile in sarcolemmal (SL), mitochondrial (MI), nuclear (NU) and
sarcoplasmic reticulum (SR) membrane fractions.
Methods: Male Wistar rats were randomly assigned to 3 dietary groups (n = 10/diet/period),
either n-3 PUFA-free diet (CTL), or ALA or DHA-rich diets. After 2 or 6 months, the subcellular
cardiac membrane fractions were separated by differential centrifugations and sucrose gradients.
Each membrane profile was analysed by gas chromatography (GC) after lipid extraction.
Results: As expected the n-3 PUFA-rich diets incorporated n-3 PUFA instead of n-6 PUFA in all
the subcellular fractions, which also exhibited individual specificities. The diet duration increased
SFA and decreased PUFA in SL, whereas NU remained constant. The SR and MI enriched in n-3
PUFA exhibited a decreased DHA level with ageing in the DHA and CTL groups. Conversely, the
n-3 PUFA level remained unchanged in the ALA group, due to a significant increase in
docosapentaenoic acid (DPA). N-3 PUFA rich diets lead to a better PUFA profile in all the fractions
and significantly prevent the profile modifications induced by ageing.
Conclusion: With the ALA diet the n-3 PUFA content, particularly in SR and SL kept increasing
between 2 and 6 months, which may partly account for the delay to achieve the modification of
adrenergic response.
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Background
Cardiac phospholipids are known to be organized into
functionally differentiated domains providing both struc-
tural integrity and a suitable microenvironment for opti-
mization of membrane protein function [1]. Furthermore,
both n-6 and n-3 polyunsaturated fatty acids (PUFA) are
important structural and functional components of cell
membrane phospholipids. An important source of dietary
n-3 PUFA is α-linolenic acid (ALA, 18:3 n-3), supplied by
vegetable sources (linseed, rapeseed, soybean, nuts),
whereas the longer chain n-3 PUFA (n-3 LCPUFA), mainly
eicosapentaenoic acid (EPA, 20:5 n-3) and docosahexae-
noic acid (DHA, 22:6 n-3), are supplied by marine prod-
ucts [2]. As reported in the literature n-3 PUFA are known
to display pleiotropic effects, and more particularly in the
prevention of cardiovascular disease (see for review [3-5]).
The beneficial cardiovascular effects of dietary n-3 PUFA
have been largely attributed to the long chain compo-
nents (n-3 LCPUFA) and this addresses the question of
the rapid decrease in the marine sources [2]. Feeding
humans or animals with vegetable sources of n-3 LCPUFA
precursor such as ALA-rich flaxseed flour could be an alter-
native, but the role of ALA on cardiovascular function and
cardio-metabolic risk remains a matter of debate. This
controversy is mainly based on the fact that an increased
consumption of ALA results in a slight increase in EPA
concentration in plasma and blood cells, but a dramati-
cally low conversion to DHA in humans [6,7]. The pro-
duction of long chains from ALA appears to be somewhat
better in rats [8,9], but depends largely on the tissue con-
sidered [8,10]. We have shown recently that if ALA can
decrease triglyceridemia, only n-3 LCPUFA prevent signif-
icantly the onset of insulin resistance in fructose-fed rats
[11]. The incorporation of n-3 PUFA was reported to
influence cardiac β-adrenergic response in cardiac cells
[12] and heart rate in vivo as reported in rat [13] and man
[14]. In a previous study, we reported a decrease in heart
rate and an increased responsiveness to β-adrenergic stim-
ulation in DHA-fed rats after 2 months [8]. Interestingly,
a similar effect was observed with an ALA-rich diet but
only after a 6-month feeding period [8]. This delay in the
onset of functional effect cannot be attributed only to the
maximal incorporation of DHA in whole heart mem-
branes that was achieved at most in 2 months with either
the DHA- or the ALA-rich diets. The present study was
designed to evaluate the hypothesis of a particular rear-
rangement of the distribution of n-3 PUFA among the dif-
ferent subcellular membranes, depending on the quality
of the dietary n-3 PUFA supplied and the duration of food
supply. Thus nuclear (NU), sarcolemmal (SL), mitochon-
drial (MI) and sarcoplasmic reticulum (SR) membranes
were separated in the myocardium of rats fed for 2 or 6
months a diet containing either DHA (from fish oil) or
ALA (from linseed flour) to analyse their fatty acid profiles
in order to explain the time-related functional effect
observed with dietary DHA and ALA.
Materials and methods
Animals and diets
The protocol complies with the institutional guidelines
for animal research (NIH Pub. No. 85-23, National
Research Council, Revised 1996) and was approved by the
Animal Care and Use Committee of the Faculty of Phar-
macy, University of Paris-Sud 11. The animal facilities are
registered under agreement number n°A 92-019-01 and
the main authors are fully authorized to manage experi-
ments on animal (agreement level I, ref. 92–261, 2006–
09-12). Five week old male Wistar-Han rats (175 ± 10 g,
Charles River, L'Abresle, France) were housed grouped by
3 or 4 and maintained at 23 ± 1°C, with a 12-h light/dark
cycle. After a 6-day acclimation period on a standard diet
(Safe A04, Villemoisson-sur-Orge, France), the rats were
randomly assigned to 3 dietary experimental groups for
either a 2- or a 6-month feeding period (n = 10/diet/
period). These experimental diets were designed as an n-3
PUFA-free diet (CTL), a DHA-rich diet (DHA), or an ALA-
rich diet (ALA). These diets were manufactured by UPAE-
INRA (INRA, Jouy-en-Josas, France) (Table 1). All diets
were designed to bring 80 g.kg-1 of lipids and similar
amount of non-lipid components. The ALA diet was based
on extruded linseed flour (Valomega 160™, Valorex, Com-
bourtillé, France) partly at the expense of the regular
ingredients used in the other diets (Table 1). In the ALA
diet, a part of the lipids was thus not brought as oil. How-
ever, it was shown that ingestion of both flax oil and
milled flaxseed deliver significant and similar levels of
ALA to the plasma, and that milled flaxseed did not
induce the adverse gastrointestinal effects observed with
oil preparations [15]. The fatty acid profile of each exper-
imental diet is presented in Table 1.
Subcellular membrane preparation
At the end of the 2 or 6 month feeding periods, the rats
were anesthetised by intraperitoneal pentobarbital injec-
tion (40 mg/kg) and killed by heart removal. Quickly dis-
sected, the hearts were washed in ice-cold HSEP buffer (50
mM Hepes, 0.30 M sucrose, 1 mM EDTA and 0.1 mM
PMSF) and immediately frozen in liquid nitrogen and
stored at -80°C. For biochemical investigation, the hearts
were thawed, rinsed with HSEP buffer, cut in small pieces
in 10 volumes of HSEP buffer and homogenised using a
polytron (three 10-s bursts separated by 30-s at setting 9).
The homogenate was fractionated according to Paris et al.
[16] with slight modifications. Briefly, the homogenate
was filtrated through cheesecloth and centrifuged (7 min,
2000 g). The pellet (P1) was re-suspended with 10 mL of
HSEP with a Stirrer Type BS Potter-Elvehjem and the sus-
pension (SN1) was centrifuged again (5 min, 2000 g). The
pellet (P2) was the nuclear membrane enriched fraction
(NU). Both supernatants were pooled (SN2) and centri-
fuged (11000 g). The pellet (P3) was re-suspended in 10
mL HSEP and centrifuged again in the same conditions.
The residual pellet (P4) was the mitochondria enrichedNutrition & Metabolism 2009, 6:14 http://www.nutritionandmetabolism.com/content/6/1/14
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fraction and the supernatants, distributed in several tubes,
were centrifuged (1 h, 70 000 g) to collect the microsomal
enriched fraction. According to Lombet et al. [17], the
microsomal fraction was distributed in 3 parts charged on
the top of 3 discontinuous sucrose density gradients (8
mL 35% sucrose, 14 mL 27% sucrose and 10 mL 15%
sucrose) and centrifuged (2 h, 23000 g). The sarcolemma
enriched fraction (SL) was collected at the 15%/27%
interface and the sarcoplasmic reticulum enriched frac-
tion (SR) at the 27%/35% interface. All the fractions were
Table 1: Formulation and fatty acid composition of the experimental diets.
CTL diet DHA diet ALA diet Extruded linseed flour5
g/kg of diet g/kg of diet g/kg of diet g/kg
Basal mix1
Protein 200
Soy protein isolate2 170 170 147
Glucides 110
Sucrose 220 220 216 35
Cornstarch 440 440 402
Fibers (mucilages, ...) 171
Cellulose 20 20 80
Minerals and other components 44
L-Cystine 5 5 5
Choline chloride 5 5 5
Mineral mixture3 50 50 48
Vitamin mixture3 10 10 10
Extruded linseed flour4 122
Lipids 280
hydrogenated coconut oil5 15.2 15 11.3
Cocoa butter6 14.4 18 25.7
Sunflower seed oil7 48 17 8.9
Rapeseed oil8 2.4 10
n-3 LCPUFA-rich oil9 20
Humidity 80
Fatty acid composition10 % of total FA % of total FA % of total FA % of total FA
14:0 4.7 4.6 3.5 -
16:0 11.2 13.2 10.2 5.9
18:0 8.5 11.4 8.4 2.9
18:1 n-9 21.7 17.5 17.0 17.3
18:2 n-6 35.5 16.9 18.2 17.7
18:3 n-3 0.6 23.3 1.4 55.1
20:5 n-3 - - 2.5 -
22:2 n-6 0.3 0.5 0.5 -
22:5 n-3 - - 16.8 -
22:6 n-3 40.6 40.7 39.8 -
Total SFA 40.6 40.7 39.8 9.1
Total MUFA 22.7 18.4 18.0 18.1
Total PUFA 36.8 40.8 42.2 72.8
Total n-6 PUFA 36.0 17.5 20.5 17.7
Total n-3 PUFA 0.7 23.4 21.7 55.1
n-6/n-3 ratio 50.6 0.7 0.9 0.3
PUFA/SFA ratio 0.9 1.0 1.1 8.0
SFA. saturated fatty acids; MUFA. monounsaturated fatty acids. PUFA. polyunsaturated fatty acids; LCPUFA. long chain PUFA.
1. The basal mix components in g/kg of diet were home-made as pellets by the UPAE (INRA). based on a formulation adapted from the AIN-93 (56).
2. MP Biomedicals 905456.
3. Mineral AIN-93M and Vitamin AIN-93VX mixtures were prepared according to AIN-93 (56). MP Biomedicals.
4. Valomega 160™. Valorex. Combourtillé. France
5. Vegetaline. SCO. France.
6. Barry Callebaut. Meulan. France
7. Fruidor. Lesieur. Antony. France
8. Rustica. France
9. Long chain n-3 PUFA-enriched oil. V0137. Laboratoire Pierre Fabre. France
10. As determined by the analysis of the manufactured experimental diets and of the experimental extruded linseed flour.Nutrition & Metabolism 2009, 6:14 http://www.nutritionandmetabolism.com/content/6/1/14
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collected in 10 mL of HEP buffer (50 mM Hepes, 1 mM
EDTA and 0.1 mM PMSF) by centrifugation (1 h, 34000
g) and kept at -80°C in 0.5 mL of HEP buffer.
Western Blot
The membrane fractions were homogenized in lysis buffer
(150 mM NaCl, 50 mM Tris, 1 mM EDTA, 1 mM PMSF,
1% Sigma inhibitor cocktail), and the protein content was
determined using the Sigma Bicinchoninic Acid Kit for
protein determination. Fraction proteins of lysates (20
μg) were separated on NuPAGE 4–12% Bis-Tris gels (Inv-
itrogen) and transferred onto a nitrocellulose membrane.
The membranes were blocked with 5% non-fat dry milk
and incubated overnight at 4°C with primary antibodies
against monoclonal Na/K ATPase (diluted 1/5000,
ab7671, Abcam, Cambridge, England), rabbit polyclonal
Cox-2 (M-19), goat polyclonal Serca2 (C-20) or rabbit
polyclonal Lamin A protein (H-102) (diluted 1/500, ref-
erences sc-1747, sc-8094 and sc-20680, respectively,
Santa-Cruz, Heidelberg, Germany) as sarcolemmal, mito-
chondrial, sarcoplasmic reticulum and nuclear markers,
respectively. Secondary specific horseradish-peroxidase
linked antibodies (diluted 1/5000, 1/10000 and 1/2500
for the rabbit, goat and mouse secondary antibodies
respectively) were added for 2 h at room temperature.
Bound antibodies were detected using the enhanced
chemiluminescence system (ECL, Amersham Bioscience)
with Kodak Biomax light films. The bands of immunob-
lots were scanned and quantified by densitometric analy-
sis using Scion Image software (Scion Corp., Frederick,
MD).
Lipid analysis
The lipids were extracted with chloroform/methanol (2/
1) according to an adaptation of the method of Folch and
Lees [18] as previously described [8]. After extraction, the
fatty acids, mostly contained in membrane phospholip-
ids, were transmethylated with Boron trifluoride metha-
nol 7% (Sigma-aldrich, Saint Quentin Fallavier, France)
according to Morrisson et al. [19]. As previously described
[13], the methyl esters of phospholipid fatty acids were
analyzed by gas chromatography coupled to FID (Auto
Sampling 8410 Gas Chromatograph 3900; Varian, Les
Ulis, France) on an Econo-Cap EC-WAX capillary column
(30-m, 0.32-mm internal diameter, 0.25-μm Film, ref
19654, ALLTECH Associates Inc, Templemars, France),
using heptadecanoic acid (margaric acid, C17:0) as inter-
nal standard. Hydrogen was used as the carrier gas. The
Unsaturation Index (UI) was calculated as UI = sum (% FA
× number of double bound).
Glycaemia, triglycerides and cholesterol assays
EDTA-plasma total cholesterol, triglyceride and glucose
levels were determined enzymatically on Modular-Roche
automate (Roche, Meylan, France).
Statistical analysis
The data were expressed as means ± SEM, n = 10. The data
obtained from each group after a 2- or 6-month period of
dietary treatment were evaluated by a 2-way ANOVA with
dietary groups and duration of dietary treatment as fixed
factors. When significantly different (P < 0.05), the means
were compared with the Newman-Keuls test. All statistical
analyses were conducted using NCSS 2000 software.
Results
Effect of dietary manipulations on plasma fatty acid 
profile and lipids
The weight gain with time was similar in the 3 dietary
groups (data not shown). Glycaemia was similar whatever
the diet. (11.4–12.5 g/L).
Plasma lipids
Plasma total cholesterol was decreased in the DHA group
(1.2 ± 0.03 g/L, p < 0.01) but remained unaffected in the
2 other groups (1.57 ± 0.08 and 1.58 ± 0.08 g/L in CTL
and ALA groups, respectively). Plasma triglyceride level
significantly decreased after 1 month in both DHA and
ALA groups and remained lower thereafter. This decrease
was significantly more pronounced in the DHA group
than in the ALA group (1.39 ± 0.11 and 1.83 ± 0.12 g/L,
respectively, p < 0.01) as compared to CTL group (2.25 ±
0.2504 g/L).
Plasma fatty acids
The quality of the dietary fatty acids significantly affected
the plasma PUFA. In the DHA-fed rats, DHA increased
largely and eicosapentaenoic acid (EPA, 20:5 n-3) and
docosapentaenoic acid (DPA, 22:5 n-3) increased in a
lower extent. In the ALA-fed rats, the main increase con-
cerned ALA, and EPA and DPA increased in a lower extent.
These n-3 PUFA increases occurred mostly at the expense
of arachidonic acid (AA, 20:4n-6) (Table 2). With time,
whatever the diet (CTL, ALA or DHA), both n-3 and n-6
PUFA content decreased in plasma fatty acids, affecting
each individual PUFA and proportionally more the n-3
PUFA, leading to an increased n-6/n-3 ratio. This decrease
with time of PUFA was parallel associated with a SFA
increase (mainly palmitic acid, 16:0), leading to a
decreased PUFA/Saturated fatty acid (PUFA/SFA, P/S)
ratio. Moreover in the two n-3 PUFA-fed groups, the
plasma fatty acid concentration was lower as compared to
the CTL-fed rats in agreement with the plasma triglyceride
content as shown above. With time, the plasma fatty acid
concentration increased significantly in CTL-fed rats, but
remained low in the two n-3 PUFA-fed groups.
Membrane fractionation
Western-Blotting analysis showed that the different frac-
tion analysed were well-separated. No contamination
from membrane fractions was observed in the cytosolicNutrition & Metabolism 2009, 6:14 http://www.nutritionandmetabolism.com/content/6/1/14
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fraction (Figure 1). We observed a very slight contamina-
tion of the NU and MI fractions by the MI and the NU
fractions, respectively. The SL, NU, MI and SR fractions
were enriched by 90%, 35%, 50% and 90% respectively as
compared to the total fraction as evaluated by densitome-
try analyses.
Effect of dietary manipulations on cardiac subcellular 
membrane fatty acid profile
Whole heart
There was no significant difference in total fatty acid con-
tent of each membrane fraction, whatever the dietary
treatment. So, presentations of fatty acid profiles were
limited to the expression of each fatty acid as percentage
of total fatty acids. In the whole heart phospholipids
(Table 3), the dietary-induced fatty acid profile changes
were similar to those reported in our previous study [8].
The proportions of SFA, monounsaturated fatty acids
(MUFA) and PUFA were weakly influenced by diet or
duration. The n-6 PUFA and n-3 PUFA contents were sig-
nificantly affected by the diet but not significantly affected
by the time, without any significant cross-interaction
between these 2 factors. The n-6 PUFA content in the total
cardiac phospholipids was 52 ± 1.0% in the CTL group
and decreased significantly (p < 0.01) with n-3 PUFA
intake after 2 months (39 ± 1.3% and 31 ± 1.3% in the
ALA and DHA groups, respectively), and remained
unchanged thereafter. Conversely, the n-3 PUFA content
in cardiac phospholipids was 5.4 ± 0.5% in the CTL group
and increased significantly (p < 0.01) with n-3 PUFA
intake after 2 months of diet (17.5 ± 1.5% and 26.0 ±
0.7% in the ALA and DHA groups, respectively) and did
not change significantly thereafter. This increase in n-3
PUFA concerned mainly the DHA in the DHA group (23–
24% of the 26% of total n-3). Conversely, in the ALA
group, DHA represented only 10% of the 17% of total n-
3) with DPA accounting for 4–5%. EPA slightly increased
in the cardiac phospholipids of the rats fed either DHA or
Table 2: Plasma fatty acid profiles (% of total fatty acids) from rats fed experimental diets for 2 or 6 months.
Duration (months) 2 2 2 6 6 6
Dietary groups CTL DHA ALA CTL DHA ALA
Fatty acids: CI
14:0 0.6 ± 0.6 0.2 ± 0.1 0.2 ± 0.0 1.0 ± 0.2 1.0 ± 0.2*** 0.8 ± 0.1 -
16:0 14.6 ± 1.3b 17.3 ± 1.4a 17.6 ± 0.8a 20.0 ± 0.8b *** 24.2 ± 0.8a *** 22.3 ± 0.8a *** -
16:1 n-9 0.2 ± 0.1 0.2 ± 0.0 0.2 ± 0.0 0.3 ± 0.0 0.3 ± 0.1*** 0.4 ± 0.0 -
16:1 n-7 1.7 ± 0.1 2.0 ± 0.6 2.2 ± 0.4 2.4 ± 0.8 2.7 ± 0.7 2.4 ± 0.8 -
18:0 12.1 ± 1.0b 12.2 ± 0.5b 13.7 ± 1.0a 12.3 ± 0.9b 13.2 ± 1.0b 14.5 ± 0.8a -
18:1 n-9 15.4 ± 0.9 16.8 ± 0.9 15.5 ± 1.0 15.4 ± 1.2* 14.9 ± 2.1* 13.9 ± 0.5* -
18:1 n-7 2.1 ± 0.2 1.8 ± 0.1 1.9 ± 0.2 2.2 ± 0.4a 1.7 ± 0.2b 1.6 ± 0.1b -
18:2 n-6 27.3 ± 1.4a 19.3 ± 1.4b 20.3 ± 1.0b 25.5 ± 1.3a * 19.0 ± 0.9b 18.7 ± 0.9b -
18:3 n-6 0.4 ± 0.1a 0.3 ± 0.1a <0.1b 0.5 ± 0.1a <0.1c 0.2 ± 0.1b -
18:3 n-3 0.3 ± 0.0b 0.7 ± 0.1b 8.4 ± 0.9a 0.3 ± 0.0b 0.7 ± 0.1b 8.1 ± 0.4a -
20:3 n-6 0.5 ± 0.1b 0.4 ± 0.1b 0.7 ± 0.2a 0.5 ± 0.1a 0.4 ± 0.1b 0.6 ± 0.1a -
20:4 n-6 21.3 ± 0.6a 7.4 ± 0.9b 7.5 ± 0.6b 16.7 ± 1.7a *** 6.7 ± 1.0b 6.7 ± 0.5b -
20:5 n-3 <0.1b 5.7 ± 0.8a 5.6 ± 0.8a <0.1c 3.4 ± 0.4b *** 4.8 ± 0.3a *** $
22:4 n-6 0.5 ± 0.1a <0.1b <0.1b 0.4 ± 0.1a <0.1b <0.1b -
22:5 n-6 0.5 ± 0.1a 0.5 ± 0.0a <0.1b 0.4 ± 0.1a 0.1 ± 0.01a <0.1b -
22:5 n-3 0.1 ± 0.0c 1.0 ± 0.2b 1.8 ± 0.2a <0.1c 0.6 ± 0.1b *** 1.4 ± 0.2a *** $
22:6 n-3 0.8 ± 0.1c 12.6 ± 0.7a 2.8 ± 0.4b 0.6 ± 0.1c 9.3 ± 0.4a *** 2.2 ± 0.3b $
SFA 27.8 ± 1.7b 30.3 ± 1.4a 32.0 ± 1.0a 33.8 ± 0.5b *** 38.9 ± 1.4a *** 38.1 ± 0.6a *** -
MUFA 19.9 ± 1.1 21.2 ± 1.6 20.2 ± 1.5 20.7 ± 2.1 19.9 ± 2.2 18.6 ± 0.8 -
PUFA 52.2 ± 0.7a 48.5 ± 2.6b 47.8 ± 1.1b 45.5 ± 2.1a *** 41.2 ± 1.8b *** 43.3 ± 0.6b *** -
n-6 PUFA 50.8 ± 0.8a 28.4 ± 2.1b 28.8 ± 1.6b 44.3 ± 2.0a *** 27.2 ± 1.6b 26.4 ± 0.9b $
n-3 PUFA 1.3 ± 0.1b 20.1 ± 1.5a 18.9 ± 1.1a 1.1 ± 0.1b 14.0 ± 0.6a *** 16.8 ± 0.7a *** $
n-6/n-3 ratio 37.9 ± 2.8a 1.4 ± 0.2b 1.5 ± 0.2b 40.1 ± 1.2a * 1.9 ± 0.1b * 1.6 ± 0.1b *-
P/S ratio 1.9 ± 0.1a 1.6 ± 0.2b 1.5 ± 0.1b 1.3 ± 0.1a *** 1.1 ± 0.1b *** 1.1 ± 0.0b *** -
[plasma FA] (μg/mL) 803 ± 6.8a 427 ± 49.7b 590 ± 35.2b 858 ± 14.4a * 441 ± 67.2b 519 ± 32.4b $
SFA. MUFA. and PUFA. saturated. monounsaturated. and polyunsaturated FA; CTL. n-3 PUFA free diet; DHA. docosahexaenoic acid-rich diet; ALA. 
alpha linolenic acid-rich diet.
Data are means ± SEM. n = 4. Dietary effect (CTL versus DHA versus ALA) was compared in rats from the same dietary treatment duration and 
values with different letters are statistically different. a>b>c. p < 0.01. Time effect (2 months versus 6 months) was compared between rats from 
the same dietary group. with * = p < 0.05; ** = p < 0.01. *** = p < 0.001). Symbol $ denoted significant cross-interaction. p < 0.05.Nutrition & Metabolism 2009, 6:14 http://www.nutritionandmetabolism.com/content/6/1/14
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ALA, but never exceeded 1% or 1.5%, respectively. Cardiac
ALA increased only in the ALA group, but never exceeded
1%. These increases in n-3 PUFA occurred mainly at the
expense of the arachidonic acid (20:4 n-6, AA). Moreover,
we did not observe significant changes in whole heart
membrane profile between 2 and 6 months of diet, except
the increase in AA in the CTL group and an increase of
linoleic acid (18:2 n-6, LA) in the ALA group. Thus, the
most significant shift between groups was the proportion
of n-6 PUFA and n-3 PUFA (p < 0.001) induced by n-3
PUFA dietary intake, as compared to the CTL group, evi-
denced by a decrease in the n-6/n-3 ratio more pro-
nounced in the DHA group than in the ALA group.
SL fraction
After 2 months of experimental diet, SL exhibited a highly
unsaturated fatty acid profile with a total PUFA content of
52–58%, SFA and MUFA representing approximately 32–
39% and 8–10%, respectively (Table 4). The SL fatty acid
profile changed with dietary n-3 PUFA intake that induced
a significant increase in DHA mostly in the DHA group
whereas EPA, DPA and DHA (in a lower extent) increased
in the ALA group. These changes mostly occurred at the
expense of AA and longer chain end-products of the n-6
PUFA series (22:4 n-6 and 22:5 n-6). DHA content was
increased 5 fold and 2 fold in the DHA and ALA groups,
respectively, as compared to CTL group which exhibited a
basal DHA content of 3.9%. SFA (mainly stearic acid,
18:0) increased with time in all the groups, mostly at the
expense of PUFA, including DHA in the DHA group and
both DPA and DHA in the ALA group. The time effect on
SFA was significantly more pronounced in the CTL group
(+ 21% between 2 and 6 months) than in the DHA and
ALA groups (+4% and +5%, respectively). Both n-6/n-3
and P/S ratios increased significantly in the CTL group
while they remained unchanged in both DHA and ALA
groups.
NU fraction
Among the various fractions, NU exhibited the lowest
PUFA content (≤ content 50%) and the highest MUFA
content (12–14%) (Table 5). In all groups, palmitic acid
(16:0) and oleic acid (18:1 n-9, OA) were predominantly
incorporated in the NU fraction. NU fraction exhibited a
2-fold higher level of OA than the other membranes in the
CTL group after 2 months of diet (10% of total fatty
acids). The NU fatty acid profile was very influenced by
the dietary fatty acids as well. Feeding the rats an n-3 PUFA
diet resulted in a NU DHA content higher in the DHA and
ALA groups (>20% and 7–8%, respectively). Interestingly,
in the ALA group, the incorporation of ALA (2.5%) and
DPA (4%) was higher in the nuclear membrane than in
any other membrane fraction. As compared to the other
membrane fractions, in the two n-3 PUFA-fed groups, NU
Specific protein markers of the different enriched fraction by Western-blotting Figure 1
Specific protein markers of the different enriched fraction by Western-blotting. Membrane fraction were lysed in a 
RIPA buffer (see material and method for the composition) and 20 μg of the lysate was used for electrophoresis. Blots from 
Serca2 and Na/KATPase were made on the same membrane after 30 min of deshybridation at 50°C with a stripping buffer 
(100 mM mercapto-ethanol, 2% SDS and 62.5 mL Tris-HCl, pH 6.7). Cox-2 and Lamin A were made also on a same membrane. 
Western blot analysis shows single protein bands of 69 kDa, 85 kDa 115 kDa and 100 kDa for Lamine A, COX-2, Na/K 
ATPase and Serca2 respectively in rat heart fractions. Each specific protein band was observed in the specific fraction with a 
slight contamination of the NU in the MI fraction and a slight presence of the MI fraction in the NU fraction. TF, total fraction; 
NU, nucleus membrane fraction, CY, cytosolic fraction; MI, mitochondrial membrane fraction; SL, sarcolemmal membrane 
fraction; SR, sarcoplasmic reticulum fraction.Nutrition & Metabolism 2009, 6:14 http://www.nutritionandmetabolism.com/content/6/1/14
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displayed a higher incorporation of n-3 PUFA and the
lowest n-6/n-3 ratio. Only the 18:1 n-7 (end-product of
the delta 9 desaturase effect on stearic acid) appeared sig-
nificantly affected in the CTL group with time. The exper-
imental duration affected three parameters (total SFA, P/S
and AA/DHA ratios), but the time effect remained
extremely weak in NU. Only the CTL group displayed a
significant increase in the AA/DHA ratio with time (signif-
icant diet/duration cross-interaction) while this ratio
remained unchanged in the two n-3 PUFA groups.
MI fraction
The MI fraction exhibited after 2 months of diet a highly
unsaturated fatty acid profile with a total PUFA content
close to 55–58%, and a SFA and MUFA contents about
33–36% and 7–10%, respectively (Table 6). All the fatty
acids were influenced by the diet, including those which
dietary supply was similar in the 3 groups. The dietary-
induced changes in MI fatty acid profile were roughly sim-
ilar to those observed in the others membrane fractions.
Both ALA and DHA diets induced a strong increase in n-3
PUFA content (22–26% and 14–16% in the DHA group
and the ALA group, respectively, as compared to 4–5% in
CTL group) and a corresponding decrease in n-6 PUFA
content particularly in the DHA group (from 55% in CTL
group to 34% and 43% in DHA and ALA groups, respec-
tively after 6 months). A time effect was observed for sev-
eral individual fatty acids in all the groups. Whatever the
group, the 18:1 n-7 decreased while 18:2 n-6 increased (a
major component of cardiolipins); 18:0 decreased in the
DHA group and 18:1 n-9 decreased in the two n-3 PUFA-
fed groups (DHA and ALA). DHA (and DPA) decreased
significantly in the CTL and DHA groups but not in the
ALA group. The increase in LA content was associated with
a significant decrease in SFA in the DHA group only. In the
CTL group only, the n-6/n-3 ratio, the P/S ratio and the
AA/DHA ratio increased significantly with time as a con-
sequence of the n-6 PUFA rise, SFA increase and the ten-
dency of AA to increase and DHA to decrease (significant
diet/duration cross-interaction), respectively. In the DHA
and ALA groups only, the LA/AA ratio increased with time
(significant diet/duration cross-interaction), while
remaining constant in the CTL group.
SR fraction
The SR also exhibited after a 2-month dietary period a
highly unsaturated fatty acid profile whatever the dietary
group (58–59% of PUFA and 6–8% of MUFA) and the
Table 3: Cardiac phospholipids fatty acid profiles (% of total fatty acids) from rats fed experimental diets for 2 or 6 months.
Duration (months) 2 2 2 6 6' 6
Dietary groups CTL DHA ALA CTL DHA ALA
Fatty Acids CI
16:0 9.8 ± 0.56 11.5 ± 0.52 11.2 ± 0.78 10.0 ± 0.76 12.3 ± 0.42 11.4 ± 0.49 -
18:0 24.9 ± 0.38 24.7 ± 0.32 25.5 ± 0.43 25.5 ± 0.48 24.7 ± 0.47 25.0 ± 0.36 -
18:1 n-9 3.5 ± 0.27 3.2 ± 0.15 3.6 ± 0.30 3.5 ± 0.14 3.2 ± 0.30 3.8 ± 0.09 -
18:1 n-7 2.9 ± 0.24a 2.2 ± 0.06b 2.6 ± 0.13ab 2.7 ± 0.11 1.9 ± 0.26 2.7 ± 0.07 -
18:2 n-6 20.5 ± 2.32 17.2 ± 1.39 20.9 ± 1.18 19.7 ± 1.63ab 17.8 ± 0.65b 22.7 ± 0.40a -
18:3 n-3 <0.1b <0.1b 0.8 ± 0.05a <0.1b <0.1b 0.9 ± 0.04a -
20:4 n-6 24.6 ± 0.66a 12.3 ± 0.32c 16.2 ± 0.46b 26.6 ± 0.73a * 12.2 ± 0.26c 15.4 ± 0.32b $
20:5 n-3 <0.1c 0.9 ± 0.05b 1.4 ± 0.06a <0.1c 0.9 ± 0.05b 1.5 ± 0.06a -
22:4 n-6 1.7 ± 0.23a <0.1b <0.1b 1.5 ± 0.04a <0.1b <0.1b -
22:5 n-6 3.9 ± 0.61a 0.8 ± 0.03b <0.1c 3.6 ± 0.07a 0.7 ± 0.01b <0.1c
22:5 n-3 0.7 ± 0.05b 0.8 ± 0.04b 4.5 ± 0.46a 0.8 ± 0.06b 0.7 ± 0.03b 4.3 ± 0.16a -
22:6 n-3 4.6 ± 0.45c 24.2 ± 0.64a 10.3 ± 1.06b 4.0 ± 0.32c 23.4 ± 0.80a 9.8 ± 0.83b -
SFA 35.6 ± 0.72 36.9 ± 0.70 37.3 ± 1.20 36.3 ± 1.26 37.8 ± 0.84 37.2 ± 0.83 -
MUFA 7.0 ± 0.49 6.1 ± 0.16 7.0 ± 0.48 6.9 ± 0.20ab 5.8 ± 0.27b 7.4 ± 0.21a -
PUFA 57.5 ± 0.81 57.0 ± 0.61 55.7 ± 1.62 56.8 ± 1.17 56.4 ± 0.89 55.4 ± 1.01 -
n-6 PUFA 52.1 ± 0.91a 31.0 ± 1.25c 38.5 ± 1.28b 51.9 ± 0.89a 31.2 ± 0.64c 38.8 ± 0.24b -
n-3 PUFA 5.4 ± 0.49c 26.0 ± 0.69a 17.1 ± 1.47b 4.8 ± 0.37c 25.2 ± 0.77a 16.5 ± 0.87b -
LA/AA ratio 0.8 ± 0.11b 1.4 ± 0.14a 1.3 ± 0.11a 0.7 ± 0.08b 1.5 ± 0.06a 1.5 ± 0.06a -
AA/DHA ratio 5.5 ± 0.48a 0.5 ± 0.02c 1.6 ± 0.17b 6.8 ± 0.73a *0 . 5  ±  0 . 0 2 c 1.6 ± 0.15b -
n-6/n-3 ratio 10.0 ± 1.08a 1.2 ± 0.08c 2.3 ± 0.21b 10.8 ± 0.73a 1.2 ± 0.05c 2.4 ± 0.12b -
P/S ratio 0.6 ± 0.02 0.6 ± 0.02 0.7 ± 0.04 0.6 ± 0.04 0.7 ± 0.03 0.7 ± 0.03 -
SFA. MUFA. and PUFA. saturated. monounsaturated. and polyunsaturated FA; CTL. n-3 PUFA free diet; DHA. docosahexaenoic acid-rich diet; ALA. 
alpha linolenic acid-rich diet.
Data are means ± SEM. n = 6. Dietary effect (CTL versus DHA versus ALA) was compared in rats from the same dietary treatment duration and 
values with different letters are statistically different. a>b>c. p < 0.01. Time effect (2 months versus 6 months) was compared between rats from 
the same dietary group. with * = p < 0.05; ** = p < 0.01. *** = p < 0.001). Symbol $ denoted significant cross-interaction. p < 0.05.Nutrition & Metabolism 2009, 6:14 http://www.nutritionandmetabolism.com/content/6/1/14
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lowest SFA content (32–34%) as compared to the other
membrane fractions (Table 7). Like the other membranes,
the SR fatty acid profile was affected by the dietary fatty
acids. In the DHA group, the DHA content after 2 months
(23%) was higher than in the other membrane fractions.
In the ALA group, SR also displayed the highest DHA con-
tent (although much lower than in the DHA group).
Thereafter, the DHA content in SR decreased significantly
with time in the CTL and DHA groups, but remained
unchanged in the ALA group. Similarly the total n-3 PUFA
decreased significantly with time in the DHA and CTL
groups, but kept increasing in the ALA group that exhib-
ited a slight increase in DHA and a higher increase in both
EPA and DPA. As a consequence, the n-6/n-3 ratio signif-
icantly increased between 2 and 6 months in the CTL
group and tended to increase in the DHA group, but
remained unchanged in the ALA group. The individual n-
3 fatty acid changes were more pronounced in the DHA
group than in the ALA group that, exhibiting different
time-induced changes, carried several significant diet/
duration cross-interaction (n-3 PUFA, AA/DHA). Interest-
ingly none of the total SFA, MUFA or PUFA was affected
by the duration of the experiment, reflecting a relative
conservation of the SR fatty acid profile with time.
Unsaturation index
The effects of dietary fatty acids and duration on the
Unsaturation Index (UI) were roughly similar in all the
subcellular membrane fractions (Figure 2). In each fraction,
the UI was significantly lower in the CTL group than in the
two n-3 PUFA-fed groups (p < 0.001). Among the fractions,
the NU membrane was the most saturated in the CTL group
after 2 and 6 months of dietary treatment (UI = 171 and
165, respectively). Feeding the rats a DHA or ALA diet
increased significantly the UI in NU, which remained unaf-
fected by duration. NU displayed a more unsaturated pro-
file in the DHA group (UI = 217 and 210 after 2 and 6
months) than in ALA group (UI = 197 and 192 after 2 and
6 months) (p < 0.001). On the contrary, SR appeared as the
most unsaturated fraction in the DHA group (UI = 244 and
238 after 2 and 6 months, respectively) and ALA group (UI
= 232 and 229 after 2 and 6 months, respectively). In SL
fraction, a significant decreased with time was observed in
the CTL group (UI = 193 and 166 after 2 and 6 months,
respectively, p < 0.001). Interestingly, this decrease was pre-
vented with the two n-3 diets, ALA and DHA (that exhib-
ited no difference of UI between 2 and 6 months).
Conversely, although the UI in MI was not influenced by
duration in the CTL group, it was moderately reduced with
Table 4: Sarcolemmal membrane fatty acid profiles (% of total fatty acids) from rats fed experimental diets for 2 or 6 months.
Duration (months) 2 2 2 6 6 6
Dietary groups CTL DHA ALA CTL DHA ALA
Fatty Acids
16:0 10.3 ± 0.28b 13.3 ± 0.39a 12.5 ± 0.36a 11.4 ± 0.87 12.9 ± 0.53 12.5 ± 0.38 -
18:0 21.6 ± 0.36 23.4 ± 0.36 22.8 ± 0.50 27.0 ± 1.50*** 25.1 ± 0.93 24.5 ± 1.00 -
18:1 n-9 4.8 ± 0.04 4.5 ± 0.28 5.5 ± 0.12 5.0 ± 0.35a 4.1 ± 0.24b 5.2 ± 0.35a -
18:1 n-7 2.9 ± 0.07 2.5 ± 0.05 2.7 ± 0.10 2.9 ± 0.17a 2.4 ± 0.06b 2.9 ± 0.13a -
18:2 n-6 26.5 ± 0.75a 21.5 ± 0.61b 26.3 ± 0.60a 22.7 ± 1.75b 22.2 ± 0.87b 26.5 ± 1.49a -
18:3 n-3 <0.1b <0.1b 1.3 ± 0.04a <0.1b <0.1b 1.1 ± 0.12a ** -
20:4 n-6 22.2 ± 0.22a 10.8 ± 0.24c 14.0 ± 0.35b 21.3 ± 1.11a 10.8 ± 0.52c 13.0 ± 0.30b -
20:5 n-3 <0.1c 0.8 ± 0.04b 1.2 ± 0.07a <0.1b 1.2 ± 0.25a 1.3 ± 0.07a -
22:4 n-6 1.2 ± 0.04a <0.1b <0.1b 1.0 ± 0.05a *** <0.1b <0.1b -
22:5 n-6 2.7 ± 0.15a 0.7 ± 0.02b <0.1c 2.5 ± 0.20a 0.5 ± 0.02b <0.1c -
22:5 n-3 0.7 ± 0.03b 0.7 ± 0.04b 3.4 ± 0.15a 0.5 ± 0.04b 0.7 ± 0.13b 2.8 ± 0.11a ** $
22:6 n-3 3.9 ± 0.10c 19.2 ± 1.01a 7.5 ± 0.32b 2.7 ± 0.10c * 17.3 ± 1.00a *6 . 5  ±  0 . 4 7 b *-
SFA 32.6 ± 0.28 37.5 ± 0.58 36.1 ± 0.60 39.5 ± 2.43** 38.8 ± 1.45 37.9 ± 1.35 -
MUFA 8.8 ± 0.11a 7.7 ± 0.34b 9.1 ± 0.25a 9.1 ± 0.50a 7.8 ± 0.32b 10.0 ± 0.47a -
PUFA 58.7 ± 0.29 54.8 ± 0.83 54.8 ± 0.59 51.4 ± 2.90** 53.4 ± 1.74 52.1 ± 1.45 -
n-6 PUFA 53.7 ± 0.29a 33.8 ± 0.61c 41.2 ± 0.39b 48.0 ± 2.78a * 34.0 ± 1.28c 40.1 ± 1.29b -
n-3 PUFA 4.9 ± 0.25c 20.9 ± 1.00a 13.6 ± 0.28b 3.3 ± 0.15c * 19.4 ± 0.88a 12.0 ± 0.62b -
LA/AA ratio 1.2 ± 0.04b 2.0 ± 0.06a 1.9 ± 0.08a 1.1 ± 0.04b 2.1 ± 0.07a 2.0 ± 0.14a -
AA/DHA ratio 5.7 ± 0.15a 0.6 ± 0.03c 1.9 ± 0.10b 8.0 ± 0.17a *** 0.6 ± 0.04c 2.1 ± 0.16b -
n-6/n-3 ratio 11.0 ± 0.57a 1.6 ± 0.10c 3.0 ± 0.05b 14.6 ± 0.50a *** 1.8 ± 0.10c 3.4 ± 0.21b -
P/S ratio 1.8 ± 0.02 1.5 ± 0.04 1.5 ± 0.04 0.8 ± 0.09b ** 1.4 ± 0.09a 1.4 ± 0.08a -
SFA. MUFA. and PUFA. saturated. monounsaturated. and polyunsaturated FA; CTL. n-3 PUFA free diet; DHA. docosahexaenoic acid-rich diet;ALA. 
alpha linolenic acid-rich diet.
Data are means ± SEM. n = 6. Dietary effect (CTL versus DHA versus ALA) was compared in rats from the same dietary treatment duration and 
values with different letters are statistically different. a>b>c. p < 0.01. Time effect (2 months versus 6 months) was compared between rats from 
the same dietary group. with * = p < 0.05; ** = p < 0.01. *** = p < 0.001). Symbol $ denoted significant cross-interaction. p < 0.05.Nutrition & Metabolism 2009, 6:14 http://www.nutritionandmetabolism.com/content/6/1/14
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time in the ALA group (UI = 226 and 217 after 2 and 6
months, respectively, significant different with p < 0.001)
and DHA groups (UI = 230 and 214 after 2 and 6 months,
respectively, significant different with p < 0.001). In the SL,
SR and MI fractions, the UI was similar in the ALA and DHA
groups (and different from CTL group, p < 0.001) both after
2 months and after 6 months.
Discussion
The aim of this study was to determine the effect of a long-
term ALA vs DHA intake subcellular membrane composi-
tion that may explain the delay required (6 months, vs 2
months, respectively) to obtain a similar functional car-
diac response (basal heart and chronotropic response)
[8]. Based on our previous observations, we hypothesized
that the fatty acid composition of the cardiac subcellular
membranes, particularly the SR and SL, because of their
strong involvement in antiarrhythmic effects [20] and car-
diac excitation-contraction coupling [21] could be differ-
ently affected by both dietary supply and duration.
Whole heart
The whole cardiac phospholipid fatty acid content was
rich in PUFA (± 56%), in the CTL group mostly from the
n-6 PUFA series (52%), but also from n-3 PUFA (± 5%,
mainly DHA). This low DHA content, which may repre-
sent a minimum cardiac requirement, should be inher-
ited, linked to the maternal stores or dietary habits [22],
or most probably in our case, due to the standard diet
(containing n-3 PUFA) used to maintain these rats from
weaning to young adult age, prior the beginning of the
present experiment. DHA intake is recommended to
increase the DHA content in cardiac phospholipids
[23,24]. We and others reported that a DHA-rich diet is
able to increase the cardiac DHA content up to 18–20% of
total fatty acids [13,24,25]. In our experimental condi-
tions in rats, ALA intake allowed cardiac membrane DHA
to increase up to 10% vs. 24% with a DHA-rich diet, as
previously reported [8].
Most of ALA is stored in adipose tissue, and some other
organs [26]. The carbon recycling pathway for the de novo
lipid synthesis consumes the majority of ALA and LA
(rather than palmitate), although another part is used in
beta-oxidation, and a small part converted to long-chain
PUFAs [27]. ALA can be efficiently elongated to DHA in
numerous mammalian tissues, including liver and brain
[9,28]. The rat cardiomyocyte was shown to be unable to
Table 5: Nuclear membrane fatty acid profiles (% of total fatty acids) from rats fed experimental diets for 2 or 6 months.
Duration (months) 2 2 2 6 6 6
Dietary groups CTL DHA ALA CTL DHA ALA
Fatty Acids CI
16:0 13.9 ± 0.4b 15.6 ± 0.46a 14.6 ± 0.33ab 13.2 ± 0.27b 15.3 ± 0.30a 14.7 ± 0.29ab -
18:0 21.0 ± 0.37 20.3 ± 0.55 20.9 ± 0.47 21.7 ± 0.25 22.0 ± 0.54 21.7 ± 0.24 -
18:1 n-9 9.7 ± 0.68a 8.2 ± 0.46b 8.7 ± 0.34ab 9.5 ± 0.61a 8.2 ± 0.57b 9.2 ± 0.36ab -
18:1 n-7 3.0 ± 0.08a 2.3 ± 0.07b 2.7 ± 0.10b 2.7 ± 0.03a *2 . 2  ±  0 . 0 7 b 2.8 ± 0.05b -
18:2 n-6 23.4 ± 0.65a 16.7 ± 0.53c 21.2 ± 0.92b 22.8 ± 0.48a 16.9 ± 0.28c 20.5 ± 0.51b -
18:3 n-3 <0.1b <0.1b 2.5 ± 0.09a <0.1b <0.1b 2.7 ± 0.12a -
20:4 n-6 18.0 ± 0.82a 9.4 ± 0.28c 13.1 ± 0.55b 19.6 ± 0.72a 9.5 ± 0.59c 12.3 ± 0.55b -
20:5 n-3 <0.1c 0.8 ± 0.05b 1.2 ± 0.06a <0.1c 0.9 ± 0.02b 1.3 ± 0.05a -
22:4 n-6 1.3 ± 0.08a <0.1b <0.1b 1.3 ± 0.07a <0.1b <0.1b
22:5 n-6 2.4 ± 0.11a 0.9 ± 0.02b <0.1c 2.6 ± 0.28a 0.8 ± 0.0b <0.1c
22:5 n-3 0.6 ± 0.07c 1.0 ± 0.07b 3.8 ± 0.26a 0.6 ± 0.05c 0.9 ± 0.03b 3.8 ± 0.05a -
22:6 n-3 3.0 ± 0.34c 21.2 ± 0.55a 7.8 ± 0.34b 2.7 ± 0.22c 20.0 ± 0.33a * 7.4 ± 0.41b -
SFA 36.2 ± 0.36 37.3 ± 0.41 36.5 ± 0.39 36.4 ± 0.34b 38.7 ± 0.34a ** 37.7 ± 0.18** -
MUFA 14.2 ± 0.66 11.9 ± 0.64 13.0 ± 0.50 13.3 ± 0.66 11.7 ± 0.69 13.5 ± 0.38 -
PUFA 49.6 ± 0.86 50.8 ± 0.67 50.6 ± 0.56 50.3 ± 0.85 49.7 ± 0.48 48.8 ± 0.45 -
n-6 PUFA 45.8 ± 0.68a 27.6 ± 0.68c 35.3 ± 0.84b 46.8 ± 0.61a 27.7 ± 0.58c 33.5 ± 0.58b -
n-3 PUFA 3.8 ± 0.39c 23.2 ± 0.63a 15.3 ± 0.58b 3.4 ± 0.25c 22.0 ± 0.30a 15.3 ± 0.41b -
LA/AA ratio 1.3 ± 0.09b 1.8 ± 0.07a 1.6 ± 0.11ab 1.2 ± 0.07b 1.8 ± 0.12a 1.7 ± 0.10a -
AA/DHA ratio 6.1 ± 0.48a 0.5 ± 0.02c 1.7 ± 0.09b 7.4 ± 0.36a *0 . 5  ±  0 . 0 3 c 1.7 ± 0.12b $
n-6/n-3 ratio 12.5 ± 1.41a 1.2 ± 0.05c 2.3 ± 0.15b 14.0 ± 0.89a 1.3 ± 0.04c 2.2 ± 0.09b -
P/S ratio 1.4 ± 0.03 1.4 ± 0.03 1.4 ± 0.03 1.4 ± 0.03 1.3 ± 0.01* 1.3 ± 0.02* -
SFA. MUFA. and PUFA. saturated. monounsaturated. and polyunsaturated FA; CTL. n-3 PUFA free diet; DHA. docosahexaenoic acid-rich diet; ALA. 
alpha linolenic acid-rich diet.
Data are means ± SEM. n = 6. Dietary effect (CTL versus DHA versus ALA) was compared in rats from the same dietary treatment duration and 
values with different letters are statistically different. a>b>c. p < 0.01. Time effect (2 months versus 6 months) was compared between rats from 
the same dietary group. with * = p < 0.05; ** = p < 0.01. *** = p < 0.001). Symbol $ denoted significant cross-interaction. p < 0.05.Nutrition & Metabolism 2009, 6:14 http://www.nutritionandmetabolism.com/content/6/1/14
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produce DHA from its precursors [29] and this was recently
confirmed in vivo [28]. The cardiac DHA content in the ALA
group may thus be provided from plasma, after transforma-
tion of ALA in the liver, as suggested in the literature [28].
It is usually assumed that LA lowers EPA synthesis because
LA is a competitive inhibitor of the metabolism of ALA
since the 2 pathways use the same enzymes [6,30]. In this
study ALA was significantly converted into higher n-3
metabolites, most probably because ALA replaced a signifi-
cant part of LA in the diet. Moreover we observed that the
stepwise increase in DHA was paralleled by a stepwise
decrease in AA, as previously reported [8,11,13,25]. Besides
the dietary-induced changes, we observed that the changes
which occurred with time in plasma fatty acid profiles
affected the membrane fatty acid profiles. The n-6/n-3 ratio
increased with time in the whole heart membrane and in
several subcellular membranes including SL, SR and MI but
only in the CTL-fed rats. Moreover, the decrease with dura-
tion in plasma P/S ratio affected the P/S ratio only in the SL
fraction and only in the CTL group.
Cardiac NU fraction
The n-3 PUFA content of the NU membrane was in the
same range as the other subcellular membranes, with a
particular incorporation of ALA and DPA in the ALA
group. PUFA (and mainly DHA) were reported to bind to
retinoid-X-receptor (RXR) [31], nuclear receptors that play
a major role in gene and protein expression involved in
lipid transport, biosynthesis and metabolism. Further-
more n-3 PUFA can also bind and stimulate PPARs that
act as lipid biosensors [32]. The high n-3 PUFA level
observed in the NU membrane is of interest and, because
of a relative proximity, may contribute to their effects on
gene regulation and expression. With time the NU mem-
brane with its higher MUFA content among the subcellu-
lar membranes, remained rather stable.
Cardiac MI fraction
The MI membrane was characterized by a significant
increase of the AA/DHA and n-6/n-3 ratios with time in
the CTL-fed rats. This phenomenon was reported in the
whole heart and particularly in mitochondria as a conse-
quence of ageing [23,33]. In this study, we observed such
alterations attributed to a loss of long chain n-3 PUFA in
MI membrane early in lifespan, in 8 months-old rats.
These time-related loss in MI long chain n-3 PUFA was
prevented by an n-3 PUFA dietary supply, according to the
present results and the literature [23,33]. Although
Table 6: Mitochondrial fatty acid profiles (% of total fatty acids) from rats fed experimental diets for 2 or 6 months.
Duration (months) 2 2 2 6 6 6
Dietary groups CTL DHA ALA CTL DHA ALA
Fatty acids CI
16:0 10.5 ± 0.37b 12.5 ± 0.51a 11.9 ± 0.13a 10.2 ± 0.33 11 ± 1.14** 10.9 ± 0.07 -
18:0 23.2 ± 0.29 22.3 ± 0.32 22.8 ± 0.12 21.4 ± 0.32ab 21 ± 2.22b * 22.5 ± 0.14a -
18:1 n-9 5.4 ± 0.51 5.2 ± 0.35 6 ± 0.18 4.8 ± 0.11 3.8 ± 0.46* 4.7 ± 0.13* -
18:1 n-7 3 ± 0.06a 2.3 ± 0.05b 2.8 ± 0.05c 2.4 ± 0.03a *** 1.9 ± 0.16b *** 2.6 ± 0.06a *** -
18:2 n-6 22.7 ± 0.66b 17.4 ± 0.94c 23 ± 0.32a 25.4 ± 0.59b *** 21.2 ± 2.19c *** 27.6 ± 0.53a *** -
18:3 n-3 <0.01b <0.01b 1.6 ± 0.06a <0.01b <0.01b 1.3 ± 0.04a *** -
20:4 n-6 23.1 ± 0.73a 11.1 ± 0.26c 14.8 ± 0.37b 24.8 ± 0.34a * 11.6 ± 1.45b 14.2 ± 0.48c -
20:5 n-3 <0.01 0.9 ± 0.04 1.3 ± 0.07 <0.01 1.0 ± 0.12b 1.4 ± 0.05a -
22:4 n-6 1.4 ± 0.05a <0.01b <0.01b 1.3 ± 0.04a <0.01b <0.01b -
22:5 n-6 3.2 ± 0.24a 0.7 ± 0.14b <0.01c 2.9 ± 0.23a 0.7 ± 0.09b <0.01c -
22:5 n-3 0.7 ± 0.03b 0.9 ± 0.05b 3.7 ± 0.08a 0.7 ± 0.02b 0.7 ± 0.09b *** 3.6 ± 0.06a -
22:6 n-3 4.4 ± 0.28c 24.5 ± 0.97a 9.4 ± 0.25b 3.4 ± 0.10c *** 20.4 ± 2.73a *** 8.2 ± 0.35b -
SFA 34.4 ± 0.21 35.5 ± 0.36 35.4 ± 0.14 32.5 ± 0.46 32.9 ± 1.02** 34.6 ± 0.12 -
MUFA 9.3 ± 0.6 8.4 ± 0.46 9.8 ± 0.26 8.4 ± 0.20a 6.7 ± 0.45b *** 8.4 ± 0.22a -
PUFA 56.3 ± 0.74 56.1 ± 0.72 54.8 ± 0.37 59.1 ± 0.63 56.2 ± 2.06 57.0 ± 0.22 -
n-6 PUFA 51 ± 0.52a 29.7 ± 1.19b 38.7 ± 0.19c 54.8 ± 0.66a *** 33.9 ± 1.04b *** 42.5 ± 0.42c *** -
n-3 PUFA 5.2 ± 0.30c 26.4 ± 1.01a 16.1 ± 0.30b 4.2 ± 0.11c 22.3 ± 1.39a *** 14.8 ± 0.36b -
LA/AA 1.0 ± 0.06b 1.6 ± 0.07a 1.6 ± 0.06a 1.0 ± 0.02b 1.8 ± 0.06a ** 2.0 ± 0.09a ** $
AA/DHA 5.3 ± 0.22a 0.5 ± 0.03c 1.6 ± 0.04b 7.4 ± 0.27a *** 0.6 ± 0.04c 1.8 ± 0.11b $
n-6/n-3 ratio 9.9 ± 0.48a 1.1 ± 0.09c 2.4 ± 0.05b 13.1 ± 0.43a *** 1.5 ± 0.09c 2.9 ± 0.10b $
P/S ratio 1.6 ± 0.03 1.6 ± 0.04 1.6 ± 0.02 1.8 ± 0.05a *** 1.7 ± 0.02a 0.6 ± 0.01b $
SFA. MUFA. and PUFA. saturated. monounsaturated. and polyunsaturated FA; CTL. n-3 PUFA free diet; DHA. docosahexaenoic acid-rich diet; ALA. 
alpha linolenic acid-rich diet.
Data are means ± SEM. n = 6. Dietary effect (CTL versus DHA versus ALA) was compared in rats from the same dietary treatment duration and 
values with different letters are statistically different. a>b>c. p < 0.01. Time effect (2 months versus 6 months) was compared between rats from 
the same dietary group. with * = p < 0.05; ** = p < 0.01. *** = p < 0.001). Symbol $ denoted significant cross-interaction. p < 0.05.Nutrition & Metabolism 2009, 6:14 http://www.nutritionandmetabolism.com/content/6/1/14
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decreasing with time, the MI DHA content remained high
after 6 months in the rats fed a DHA-rich diet. Interest-
ingly, in the rats fed an ALA-rich flour based diet, the age-
related loss in DHA was not significant. Such changes in
MI fatty acid profile may have profound functional conse-
quences on the efficiency of membrane proteins involved
in numerous processes including ion homeostasis and
intracellular signal transduction, free radical metabolism
and energy production [33]. In the diabetic heart, the
functional activity of mitochondria is reduced partially
because of the alteration of cardiolipin turnover, which
can be improved when DHA increased in the mitochon-
drial membrane [34]. The effect of DHA on PPARα may
contribute to the stimulation of cardiolipin synthesis, as
already suggested [35]. In both DHA and ALA groups, the
LA/AA ratio increased with time in MI, but not in the CTL
group. As far as cardiolipin contains approximately 75%
of LA, a stimulation of cardiolipin synthesis by n-3 long
chain PUFA may account increased content of LA in MI
fraction. Several authors suggested that the loss of n-3
PUFA with time may constitute a protection against lipid
peroxidation [36], although recent works reported that
restoring a high level of n-3 PUFA in old rats reversed cel-
lular dysfunctions, including mitochondrial energy pro-
duction, tolerance to ischemia and reperfusion and Ca2+
metabolism [33].
Cardiac SL and SR fractions
The most important time-induced variations occurred in
the SL in the CTL group. The SFA content increased while
the total PUFA significantly decreased affecting signifi-
cantly n-6 and even more n-3 PUFA contents, as revealed
by the highly significant increase in n-6/n-3 and AA/DHA
ratios. Like MI, SL displayed a significant decrease in DHA
with time, whatever the dietary group and the dietary n-3
PUFA supply strongly attenuated the time-induced total
n-3 PUFA loss in SL. To our knowledge, the prevention by
dietary n-3 PUFA of the time-induced changes in cardiac
SL has not been reported in the literature.
Among the different membrane fractions investigated, the
SR was the richest in PUFA and this high PUFA content
was preserved throughout the experimental duration,
whatever the dietary group. Unlike other membranes, SR
displayed a significant cross-interaction between duration
and diets, in the two n-3 PUFA groups. The SR DHA con-
tent decreased in DHA-fed rats whereas it was maintained
and DPA was increased in ALA-fed rats. As a consequence,
Table 7: Sarcoplasmic reticulum fatty acid profiles (% of total fatty acids) from rats fed experimental diets for 2 or 6 months.
Duration (months) 2 2 2 6 6 6
Dietary groups CTL DHA ALA CTL DHA ALA
Fatty acids CI
16:0 9.1 ± 0.36c 11.2 ± 0.35a 10.5 ± 0.33b 9.5 ± 0.46b 11 ± 0.22a 10.2 ± 0.05ab -
18:0 22.9 ± 0.31 22.5 ± 0.36 22.3 ± 0.26 23.2 ± 0.4 22.6 ± 0.22 22.8 ± 0.12 -
18:1 n-9 4.6 ± 0.18a 3.7 ± 0.13b 4.9 ± 0.10a 4.1 ± 0.13a ** 3.4 ± 0.14b 4.1 ± 0.1a ** -
18:1 n-7 2.9 ± 0.06a 2.3 ± 0.05c 2.6 ± 0.07b 2.5 ± 0.08a *** 2.1 ± 0.07b *** 2.6 ± 0.05a $
18:2 n-6 25.8 ± 0.54b 20.9 ± 0.76c 26.9 ± 0.61a 26.1 ± 0.45a 23.4 ± 0.36b * 26.8 ± 0.65a -
18:3 n-3 <0.01 <0.01 1.3 ± 0.05 <0.01 <0.01 1.2 ± 0.04**
20:4 n-6 23.3 ± 0.57a 11.7 ± 0.27b 14.8 ± 0.41b 24.4 ± 0.64a 11.8 ± 0.51b 15.1 ± 0.58b -
20:5 n-3 <0.01 0.9 ± 0.04 1.1 ± 0.28 <0.01 1.0 ± 0.03b 1.5 ± 0.03a*
22:4 n-6 1.3 ± 0.03 <0.01 <0.01 1.1 ± 0.04*** <0.01 <0.01
22:5 n-6 3.1 ± 0.23a 0.8 ± 0.02a <0.01 2.8 ± 0.24b 0.7 ± 0.01a <0.01
22:5 n-3 0.7 ± 0.03b 0.8 ± 0.04b 3.5 ± 0.13a 0.6 ± 0.03b 0.7 ± 0.03b 3.9 ± 0.06a *$
22:6 n-3 4.2 ± 0.16c 23 ± 0.70a 8.9 ± 0.46b 3.2 ± 0.14c 20.9 ± 0.24a ** 9 ± 0.36b $
SFA 32.8 ± 0.41 34.4 ± 0.32 33.8 ± 0.33 33.2 ± 0.84 34.2 ± 0.12 33.6 ± 0.09 -
MUFA 8.2 ± 0.24a 6.9 ± 0.16b 8.6 ± 0.28a 7.8 ± 0.30a 6.6 ± 0.23b 8 ± 0.08a -
PUFA 59 ± 0.63 58.7 ± 0.38 57.6 ± 0.52 58.9 ± 1.11 59.1 ± 0.26 58.4 ± 0.09 -
n-6 PUFA 54 ± 0.65a 34 ± 0.79c 42.7 ± 0.66b 54.9 ± 1.01a 36.4 ± 0.43c * 42.6 ± 0.35b -
n-3 PUFA 5 ± 0.17c 24.8 ± 0.70a 14.8 ± 0.68b 4 ± 0.16c * 22.7 ± 0.24a * 15.7 ± 0.36b $
LA/AA 1.1 ± 0.05b 1.8 ± 0.08a 1.8 ± 0.07a 1.1 ± 0.02b 2 ± 0.10a 1.8 ± 0.10a -
AA/DHA 5.6 ± 0.20a 0.5 ± 0.02c 1.7 ± 0.09b 7.7 ± 0.26a *** 0.6 ± 0.03c 1.7 ± 0.10b $
n-6/n-3 ratio 10.9 ± 0.43a 1.4 ± 0.07c 2.9 ± 0.18b 13.9 ± 0.41a *** 1.6 ± 0.03c 2.7 ± 0.09b $
P/S ratio 1.8 ± 0.04 1.7 ± 0.03 1.7 ± 0.03 1.7 ± 0.07 1.7 ± 0.01 1.7 ± 0.01 -
SFA. MUFA. and PUFA. saturated. monounsaturated. and polyunsaturated FA; CTL. n-3 PUFA free diet; DHA. docosahexaenoic acid-rich diet; ALA. 
alpha linolenic acid-rich diet.
Data are means ± SEM. n = 6. Dietary effect (CTL versus DHA versus ALA) was compared in rats from the same dietary treatment duration and 
values with different letters are statistically different. a>b>c. p < 0.01. Time effect (2 months versus 6 months) was compared between rats from 
the same dietary group. with * = p < 0.05; ** = p < 0.01. *** = p < 0.001). Symbol $ denoted significant cross-interaction. p < 0.05.Nutrition & Metabolism 2009, 6:14 http://www.nutritionandmetabolism.com/content/6/1/14
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Membrane unsaturation indexes Figure 2
Membrane unsaturation indexes. The unsaturation index is the sum of the percentages of each FA in a fraction multiplying 
by the number of the considered fatty acid double bound. SL, sarcolemmal; NU, nuclear; MI, mitochondrial; SR, sarcoplasmic 
membrane. Data are means ± SEM, n = 6. Dietary effect (CTL versus DHA versus ALA) was compared in rats from the same 
dietary treatment duration and values with different letters are statistically different, a>b>c, p < 0.01. Time effect (2 months 
versus 6 months) was compared between rats from the same dietary group, with * = p < 0.05 and *** = p < 0.001.Nutrition & Metabolism 2009, 6:14 http://www.nutritionandmetabolism.com/content/6/1/14
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The total C22 n-3 content in SR slightly decreased with
time in the DHA group but kept increasing with time in
the ALA group.
These modifications in SL and SR may affect the activity of
ion channels and proteins, mainly those involved in the
excitation-contraction coupling. Dietary n-3 PUFA-
induced n-3 PUFA membrane enrichment was reported to
play a key role in cardiac β-adrenergic function [8,37] and
calcium signalling [20,21,38]. Numerous studies, mostly
in cultured cardiac cells, strongly suggested that changes
of the physical state of the SL membrane, particularly
affecting the phospholipid fatty acids of the membrane
micro-domain surrounding the receptors, influence or co-
regulate the functionality and the number of assayable of
β-adrenergic receptors [39,40]. Other functions were
reported to be influenced by membrane n-3 PUFA,
including transient outward current, L-type Ca2+ current,
voltage-dependant Na+ current, and Ca2+-Mg2+-ATPase in
SL and ryanodine channel, Na+-Ca2+-exchanger, Ca2+
uptake in SR (see for review [41]).
Moreover, the age-related changes in the activity of these
various membrane-bound protein systems were also
shown to be prevented by long chain n-3 PUFA supply (see
for review [42]). The ALA-rich diet did not allow to reach
the same DHA content than the DHA diet. However in the
ALA group, the total n-3 PUFA in SR kept increasing with
time, while it decreased in the other groups. By comparison
with the functional effects previously reported with the
same diets [8], the present study suggests that the delayed
effect of ALA diet (on heart rate and adrenergic response)
may be due to the evolution with time of individual subcel-
lular membranes: (i) in SR, the C22 n-3 content kept
increasing after 6 months of diet with ALA supply but not
with DHA supply, suggesting the importance of C22 n-3 in
the regulation of ryanodine receptor function; (ii) in SL,
although decreasing with time, the DHA (and DPA) con-
tent remains high enough to account for the regulation of
beta-adrenergic receptor function both in ALA group and
DHA group. Whatever the membrane fraction considered,
DHA and ALA induced a significant rise in membrane
unsaturation after 2 months, suggesting an increased mem-
brane fluidity. Recently [43] the introduction of DHA-rich
domains into the sarcolemma and their coexistence with
lipid rafts was suggested to account for the diversity of
health benefits associated to DHA intake. The changes in
the conformation of signalling-involved proteins, when
they move among these disparate domains, may have the
potential to modulate cell function.
Conclusion
Although not achieving a similar level of DHA in the
membranes, an ALA-rich diet was characterized by an
ability to keep increasing the total n-3 PUFA during the
time course of the experiment, mainly in SR. This unique
property may explain partly why in previous paper, the
adrenergic response was observed after 2 months with a
DHA diet, but after 6 months with an ALA diet. The differ-
ence of n-3 PUFA content in plasma membrane (SL) and
sarcoplasmic reticulum (SR), both involved in the
chronotropic response to adrenergic stimulation,
decreased with time between in ALA group and DHA
group. Indeed the n-3 PUFA content decreased in the
DHA group after 6 months and increased after 2 months
in the ALA group. Although the n-3 PUFA supply (either
ALA or DHA) prevented the alteration of membrane P/S
ratio, whatever the membrane fraction and whatever the
diet duration. These observations brought some evidences
of the interest of introducing as well in longer-term die-
tary experiments, the essential fatty acid ALA as compared
to the end-product metabolite in the n-3 pathway, namely
DHA, in order to investigate a possible dietary impact on
health.
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